Clinical Trial Update: Effect of Istradefylline Treatment on Behavioral Measures of Apathy in Parkinson's Disease.

View source ↗

Summary

The clinical trial evaluating istradefylline for apathy in Parkinson's disease was terminated, with no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Nourianz (istradefylline)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Apathy, Parkinson Disease | Status: TERMINATED